Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Non-Current Assets

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Non-Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Assets ₹5,630 Cr₹5,881 Cr₹6,840 Cr₹7,115 Cr₹6,709 Cr

What is the latest Total Non-Current Assets ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Non-Current Assets ratio of GLENMARK PHARMACEUTICALS is ₹5,630 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Assets
Mar2025₹5,630 Cr
Mar2024₹5,881 Cr
Mar2023₹6,840 Cr
Mar2022₹7,115 Cr
Mar2021₹6,709 Cr

How is Total Non-Current Assets of GLENMARK PHARMACEUTICALS Trending?

Years Total Non-Current Assets % Change
Mar2025 ₹5,630 Cr
-4.27
Mar2024 ₹5,881 Cr
-14.03
Mar2023 ₹6,840 Cr
-3.86
Mar2022 ₹7,115 Cr
6.04
Mar2021 ₹6,709 Cr -

Compare Total Non-Current Assets of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹58,301.1 Cr 2.9% 5.1% 25.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹414,929.0 Cr 0.7% -4.2% -8.7% Stock Analytics
DIVIS LABORATORIES ₹169,644.0 Cr 0% -1% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹131,481.0 Cr 2.4% 4.5% 14.5% Stock Analytics
CIPLA ₹122,050.0 Cr 1.1% 0.2% -1.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,784.0 Cr -1% -2% -9.7% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

2.9%

5.1%

25.9%

SENSEX

0.9%

0.7%

9.6%


You may also like the below Video Courses